CureVac
Sebastian Boldt is a seasoned professional in quality management with a focus on the biotechnology sector. Currently serving as the Senior Quality Manager QC and Head of Quality Control at CureVac since June 2022, Sebastian previously held the position of QA Manager at AMINO GmbH from June 2021 to May 2022, specializing in Supplier Qualification and Management. An academic background in chemistry culminated in a Doctorate degree in Organic Chemistry from Universität Rostock, where Sebastian also attained a Master of Science and a Bachelor of Science in Chemistry.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.